MEDZYM

Medzym is in the process of developing formulations of ocular solutions for eye diseases and their prevention. Medzym's technology presents the first major leap forward in the treatment and possible prevention of Glaucoma. This drug candidate can be used topically. Preliminary (fast and crude experiments) indicate that the primary component in the formulation is active and well characterized. The formulation is expected to be non-toxic under natural physiological conditions. The primary compound is stable at room temperature for more than one month... At Medzym we have developed a drug delivery technology based on Nano-Molecular Science (NMS). Delivery of a drug via an NMS-based product may be a good start to fulfill the main objective: enhancement of drug permeation. Our NMS technology provides a unique formulation and an effective solution to the current problems.

Also known as: Medzym, Inc.

Primary location: San Jose United States